BRPI0511864A - uso de uma combinação de etinilestradiol e acetato de clormadinona para a preparação de um medicamento - Google Patents
uso de uma combinação de etinilestradiol e acetato de clormadinona para a preparação de um medicamentoInfo
- Publication number
- BRPI0511864A BRPI0511864A BRPI0511864-6A BRPI0511864A BRPI0511864A BR PI0511864 A BRPI0511864 A BR PI0511864A BR PI0511864 A BRPI0511864 A BR PI0511864A BR PI0511864 A BRPI0511864 A BR PI0511864A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- combination
- acetate
- medicament
- ethinyl estradiol
- Prior art date
Links
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 title abstract 3
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 title abstract 3
- 229960002568 ethinylestradiol Drugs 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 title 1
- QMBJSIBWORFWQT-DFXBJWIESA-N Chlormadinone acetate Chemical compound C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 QMBJSIBWORFWQT-DFXBJWIESA-N 0.000 abstract 2
- 230000027758 ovulation cycle Effects 0.000 abstract 2
- 208000005171 Dysmenorrhea Diseases 0.000 abstract 1
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract 1
- 239000003098 androgen Substances 0.000 abstract 1
- 229960001616 chlormadinone acetate Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000002657 hormone replacement therapy Methods 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 230000006641 stabilisation Effects 0.000 abstract 1
- 238000011105 stabilization Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
USO DE UMA COMBINAçãO DE ETINILESTRADIOL E ACETATO DE CLORMADINONA PARA A PREPARAçãO DE UM MEDICAMENTO. A invenção se refere ao uso de uma combinação de etinilestradiol e acetato de clormadinona para a preparação de um medicamento, que é utilizado simultaneamente para o tratamento de alterações causadas por androgênios, para a terapia hormonal substitutiva, para o tratamento da dismenorréia, para a estabilização do ciclo menstrual, para o tratamento de doenças resultantes do ciclo menstrual e para a anticoncepção em mulheres.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004026669A DE102004026669A1 (de) | 2004-05-28 | 2004-05-28 | Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels |
| PCT/EP2005/005764 WO2005115402A1 (de) | 2004-05-28 | 2005-05-27 | Verwendung einer kombination aus ethinylestradiol und chlormadinonacetat zur herstellung eines arzneimittels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0511864A true BRPI0511864A (pt) | 2008-01-22 |
Family
ID=34982562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0511864-6A BRPI0511864A (pt) | 2004-05-28 | 2005-05-27 | uso de uma combinação de etinilestradiol e acetato de clormadinona para a preparação de um medicamento |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050267081A1 (pt) |
| EP (1) | EP1753435A1 (pt) |
| AR (1) | AR049195A1 (pt) |
| AU (1) | AU2005247101B2 (pt) |
| BR (1) | BRPI0511864A (pt) |
| DE (1) | DE102004026669A1 (pt) |
| EC (1) | ECSP067030A (pt) |
| MX (1) | MXPA06013800A (pt) |
| PE (1) | PE20060402A1 (pt) |
| RU (1) | RU2394579C2 (pt) |
| WO (1) | WO2005115402A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004026671A1 (de) * | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Darreichungsform zur hormonalen Kontrazeption |
| DE102006003508A1 (de) * | 2006-01-24 | 2007-07-26 | Grünenthal GmbH | Arzneimittel umfassend eine Hormonkombination |
| DE102006003509A1 (de) * | 2006-01-24 | 2007-07-26 | Grünenthal GmbH | Kontrazeptivum |
| DE102006062119A1 (de) * | 2006-12-22 | 2008-06-26 | Grünenthal GmbH | Arzneimittel zur Behandlung von Hauterkrankungen |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
| AU4805085A (en) * | 1984-09-05 | 1986-03-24 | Schering Aktiengesellschaft | Mittel zur behandlung von androgenisierungserscheinungen und verwendung von antiandrogenen zur herstellung des mittels |
| DE3916112A1 (de) * | 1989-05-16 | 1990-11-22 | Schering Ag | Dihydrospirorenon als antiandrogen |
| DE4104385C1 (pt) * | 1991-02-09 | 1992-08-13 | Marika Dr.Med. 6509 Framersheim De Ehrlich | |
| US5468736A (en) * | 1993-02-25 | 1995-11-21 | The Medical College Of Hampton Road | Hormone replacement therapy |
| DE19525017A1 (de) * | 1995-06-28 | 1997-01-02 | Schering Ag | Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption |
| US6511970B1 (en) * | 1996-09-13 | 2003-01-28 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
| DE19739916C2 (de) * | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
| US6326392B1 (en) * | 1997-11-06 | 2001-12-04 | American Home Products Corporation | Anti-estrogen plus progestin containing oral contraceptives |
| CN1644201A (zh) * | 1998-04-17 | 2005-07-27 | 奥索-麦克尼尔药品公司 | 含有叶酸的药用组合物的用途 |
| US6265393B1 (en) * | 1998-08-07 | 2001-07-24 | Heinrichs William Leroy | Prevention of endometriosis signs or symptons |
| NZ534348A (en) * | 2000-01-28 | 2006-06-30 | Endorech Inc | Selective estrogen receptor modulators in combination with estrogens |
| DE10045380A1 (de) * | 2000-09-14 | 2002-04-04 | Schering Ag | Verfahren zur Kontrazeption und dessen Darreichungsform |
| PT1390040E (pt) * | 2001-05-18 | 2007-04-30 | Pantarhei Bioscience Bv | Composição farmacêutica para ser utilizado na terapia hormonal de substituição. |
| CA2494687A1 (en) * | 2002-08-15 | 2004-02-26 | Wyeth | Agonism of the 5ht2a receptor for treatment of thermoregulatory dysfunction |
| US7772219B2 (en) * | 2003-05-02 | 2010-08-10 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
-
2004
- 2004-05-28 DE DE102004026669A patent/DE102004026669A1/de not_active Withdrawn
- 2004-12-10 US US11/009,361 patent/US20050267081A1/en not_active Abandoned
-
2005
- 2005-05-27 EP EP05763426A patent/EP1753435A1/de not_active Ceased
- 2005-05-27 BR BRPI0511864-6A patent/BRPI0511864A/pt not_active Application Discontinuation
- 2005-05-27 MX MXPA06013800A patent/MXPA06013800A/es active IP Right Grant
- 2005-05-27 WO PCT/EP2005/005764 patent/WO2005115402A1/de not_active Ceased
- 2005-05-27 AR ARP050102211A patent/AR049195A1/es unknown
- 2005-05-27 RU RU2006145077/15A patent/RU2394579C2/ru active
- 2005-05-27 PE PE2005000595A patent/PE20060402A1/es not_active Application Discontinuation
- 2005-05-27 AU AU2005247101A patent/AU2005247101B2/en not_active Ceased
-
2006
- 2006-11-27 EC EC2006007030A patent/ECSP067030A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005247101A1 (en) | 2005-12-08 |
| PE20060402A1 (es) | 2006-07-12 |
| ECSP067030A (es) | 2006-12-29 |
| DE102004026669A1 (de) | 2005-12-15 |
| US20050267081A1 (en) | 2005-12-01 |
| AR049195A1 (es) | 2006-07-05 |
| RU2006145077A (ru) | 2008-07-10 |
| WO2005115402A1 (de) | 2005-12-08 |
| MXPA06013800A (es) | 2007-02-02 |
| AU2005247101B2 (en) | 2011-02-17 |
| RU2394579C2 (ru) | 2010-07-20 |
| EP1753435A1 (de) | 2007-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE493132T1 (de) | Arzneimittel umfassend wenigstens ein gestagen | |
| MX363536B (es) | Gel transdermico de progestina/estradiol. | |
| AR057060A1 (es) | Composiciones de tanaproget que contienen etinil estradiol | |
| EA201201403A1 (ru) | Очень низкодозированные твердые пероральные лекарственные формы для гзт | |
| EA200900491A1 (ru) | Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола | |
| AR049112A1 (es) | Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual | |
| BR112022011445A2 (pt) | Composição imunoestimuladora e uso da mesma | |
| UY33470A (es) | Derivados de 6,7-dihidro-5h-benzo[7]anulenos, métodos para su preparación, preparaciones farmacéuticas que los contienen y su uso para la preparación de medicamentos | |
| CU20140064A7 (es) | Derivados de 6,7- dihidro-5h-benzo[7]anuleno, procesos para su preparación, productos farmacéuticos que comprenden a los mismos y su uso en la preparación de medicamentos | |
| DK1443966T3 (da) | Fremgangsmåde til forebyggelse eller behandling af benigne gynækologiske lidelser | |
| BR0309780A (pt) | Tratamento da hipertensão em mulheres recebendo terapia de reposição hormonal | |
| AR033042A1 (es) | Terapia de reemplazo hormonal | |
| PE20040068A1 (es) | Decanoato, undecanoato y dodecanoato de etonogestrel | |
| PE20070344A1 (es) | Regimenes para la administracion de las unidades de dosificacion de anticonceptivos monofasicos orales | |
| EE05259B1 (et) | Antiprogestiinide kasutamine hormoons?ltuvate haiguste proflaktikaks ja raviks | |
| BRPI0614415A2 (pt) | método de indução de contracepção, terapia de reposição hormonal, tratamento de doença dependente de hormônio, sincronização de estro, ou tratamento de sintomas relacionados com ciclo em um mamífero, regime de contracepção, uso de um composto, composto, e, produto de contracepção | |
| ATE270554T1 (de) | Kombination der progesteron und mifepristone für krebs-therapie | |
| BRPI0511864A (pt) | uso de uma combinação de etinilestradiol e acetato de clormadinona para a preparação de um medicamento | |
| CL2023000450A1 (es) | Nueva composición de anticonceptivo oral de liberación modificada | |
| HRP20090256T1 (en) | Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method | |
| DE502006000771D1 (de) | Feste perorale arzneiform zur kontrazeption, die dienogest und ethinylestradiol enthält | |
| NO20072687L (no) | Farmasoytisk prevensjonspreparat | |
| BRPI0511931A (pt) | uso de 7-t-butoxiiminometilcamptotecina para a preparação de um medicamento para o tratamento de neoplasmas uterinos | |
| CY1112775T1 (el) | Χρηση βαλεριανικης οιστραδιολης σε συνδυασμο με dienogest για την απο του στοματος θεραπεια της δυσλειτουργικης αιμορραγιας της μητρας σε ενοτητα με αντισυλληψη απο του στοματος | |
| TW200744609A (en) | Process for producing a single-phase pharmaceutical product for oral therapy of dysfunctional uterine bleeding |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: RICHTER GEDEON NYRT. (HU) |
|
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07B | Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |